Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Annals of Behavioral Medicine
Erschienen in: Annals of Behavioral Medicine 1/2013

01.02.2013 | Original Article

Worry About Cancer Progression and Low Perceived Social Support: Implications for Quality of Life Among Early-Stage Breast Cancer Patients

verfasst von: Erika A. Waters, PhD, MPH, Ying Liu, MD, PhD, Mario Schootman, PhD, Donna B. Jeffe, PhD

Erschienen in: Annals of Behavioral Medicine | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Worry about cancer progression and perceived social support can affect cancer survivors’ quality of life (QOL).

Methods

In 480 early-stage breast cancer survivors, we examined how worry about cancer progression and perceived social support 6 months after definitive surgery were associated with QOL (RAND 36-item Health Survey) at 6-, 12-, and 24-month follow-up.

Results

At 6 months post-surgery, higher worry was associated with worse QOL for five of eight subscales. Lower social support was associated with worse QOL for four subscales. The negative effects of worry and limited social support dissipated for four subscales (worry) and two subscales (social support) by 12-month follow-up and for all subscales by 24-month follow-up. Social support at 6 months moderated the relationship between T2 worry and T4 emotional well-being; post hoc tests did not clarify the nature of the interaction.

Conclusion

Early-stage breast cancer survivors who worry about cancer progression and/or have low social support may experience lower levels of QOL that can take several months to resolve.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
O’Connor AM, Bennett CL, Stacey D, Barry M, Col NF, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst. Rev. 2009; 3.
2.
3.
Institute of Medicine. From cancer patient to cancer survivor: Lost in translation. Washington, DC: The National Academies; 2006:506.
4.
5.
Herschbach P, Keller M, Knight L, Brandl T, Huber B, Henrich G, et al. Psychological problems of cancer patients: A cancer distress screening with a cancer-specific questionnaire. Br J Cancer. 2004;91(3):504-511.PubMedCrossRef
6.
Mehnert A, Berg P, Henrich G, Herschbach P. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology. 2009;18(12):1273-1280.PubMedCrossRef
7.
Waters EA, Arora NK, Klein WMP, Han PKJ. Perceived risk, trust and health-related quality of life among cancer survivors. Ann Behav Med. 2010;39(1):91-97.PubMedCrossRef
8.
Bloom JR, Stewart SL, Oakley-Girvan I, Banks PJ, Shema S. Quality of life of younger breast cancer survivors: Persistence of problems and sense of well-being. Psychooncology. 2012;21(6):655-665.PubMedCrossRef
9.
Ashing-Giwa KT, Lim JW. Examining emotional outcomes among a multiethnic cohort of breast cancer survivors. Oncol Nurs Forum. 2011;38(3):279-288. Epub 2011/05/03.PubMedCrossRef
10.
Partridge A, Adloff K, Blood E, Dees C, Kaelin C, Golshan M, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: Longitudinal results from a cohort study. J Natl Cancer Inst. 2008;100:243-251.PubMedCrossRef
11.
Liu Y, Perez M, Schootman M, Aft RL, Gillanders WE, Jeffe DB. Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer. Breast Canc Res Treat. 2011;130(1):165-173.CrossRef
12.
Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6):704-714.CrossRef
13.
Kwan ML, Ergas IJ, Somkin CP, Quesenberry CPJ, Neugut AI, Hershman DL, et al. Quality of life among women recently diagnosed with invasive breast cancer: The Pathways Study. Breast Cancer Res Treat. 2010;123(2):507-524.PubMedCrossRef
14.
Kornblith AB, Herndon JE, Zuckerman E, Viscoli CM, Horwitz RI, Cooper MR, et al. Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer. 2001;91(2):443-454.PubMedCrossRef
15.
Lewis JA, Manne SL, DuHamel KN, Vickburg SM, Bovbjerg DH, Currie V, et al. Social support, intrusive thoughts, and quality of life in breast cancer survivors. J Behav Med. 2001;24(3):231-244.PubMedCrossRef
16.
Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull. 1985;98(2):310-357.PubMedCrossRef
17.
Collins KK, Liu Y, Schootman M, Aft R, Yan Y, Dean G, et al. Effects of breast cancer surgery and surgical side effects on body image over time. Breast Cancer Res Treat. 2011;126(1):167-176. Epub 2010/08/06.PubMedCrossRef
18.
Kwan ML, Ergas IJ, Somkin CP, Quesenberry CP Jr, Neugut AI, Hershman D, et al. Quality of life among women recently diagnosed with invasive breast cancer: The Pathways Study. Breast Cancer Res Treat. 2010;123(2):507-524. Epub 2010/02/09.PubMedCrossRef
19.
Michael YL, Kawachi I, Berkman LF, Holmes MD, Colditz GA. The persistent impact of breast carcinoma on functional health status: Prospective evidence from the Nurses’ Health Study. Cancer. 2000;89(11):2176-2186. Epub 2001/01/09.PubMedCrossRef
20.
Jeffe DB, Perez M, Liu Y, Collins KK, Aft RL, Schootman M. Quality of life changes over time in women diagnosed with ductal carcinoma in situ, early-stage invasive, breast cancer, and age-matched controls. Breast Cancer Res Treat. 2012;134(1):379-391.PubMedCrossRef
21.
Epstein RM, Street RLJ. Patient-centered communication in cancer care: Promoting healing and reducing suffering. Bethesda, MD: National Cancer Institute, 2007 NIH Publication No. 07–6225.
22.
Hesse BW, Arora NK, Burke Beckjord E, Finney Rutten LJ. Information support for cancer survivors. Cancer. 2008;112(Suppl 11):2529-2540.PubMedCrossRef
23.
24.
25.
Stanton AL. What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol. 2012;30(11):1215-1220. Epub 2012/03/14.PubMedCrossRef
26.
Perez M, Liu Y, Schootman M, Aft RL, Schechtman KB, Gillanders WE, et al. Changes in sexual problems over time in women with and without early-stage breast cancer. Menopause. 2010;17(5):924-937. Epub 2010/05/13.PubMedCrossRef
27.
Leitch AM, Dodd GD, Costanza M, Linver M, Pressman P, McGinnis L, et al. American Cancer Society guidelines for the early detection of breast cancer: Update 1997. CA Cancer J Clin. 1997;47:150-153.PubMedCrossRef
28.
Carrera C, Payne S. Ductal carcinoma in situ (DCIS) of the breast: The need for psychosocial research. Psychooncology. 1999;8(6):538-545. Epub 1999/12/23.PubMedCrossRef
29.
Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatr. 1983;140:734-739.PubMed
30.
Ware JE, Sherbourne DC. The MOS 36-item Short Form Health Survey (SF-36). Med Care. 1992;30:473-483.PubMedCrossRef
31.
Hays RD, Sherbourne CD, The MRM. The RAND 36-Item Health Survey 1.0. Health Economics. Health Econ. 1993;2(3):217-227.PubMedCrossRef
32.
Spielberger CD, Gorsuch RL, Lushene RE. Test manual for the State-Trait Anxiety Inventory. Palo Alto: Consulting Psychologists Press; 1970.
33.
Stevens JP. Applied multivariate statistics for the social sciences. 4th ed. Mahwah: Lawrence Erlbaum Associates; 2002:703.
34.
SAS Institute Inc. SAS/STAT user’s guide. 9.2 edn. Cary, NC2011.
35.
Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Erlbaum; 1988.
36.
Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 1999;52(9):861-873. Epub 1999/10/21.PubMedCrossRef
37.
Hays RD, Farivar SS, Liu H. Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. Copd. 2005;2(1):63-67. Epub 2006/12/02.PubMedCrossRef
38.
Bardwell WA, Major JM, Rock CL, Newman VA, Thomson CA, Chilton JA, et al. Health-related quality of life in women previously treated for early-stage breast cancer. Psychooncology. 2004;13(9):595-604. Epub 2004/08/31.PubMedCrossRef
39.
Kornblith AB. Psychosocial adaptation of cancer survivors. In: Holland JC, ed. Psychooncology. New York: Oxford University Press; 1998:223-254.
40.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomized trials. Lancet. 2005;365:1687-1717.CrossRef
41.
Meijnen P, Oldenburg HAS, Peterse JL, Bartelink H, Rutgers EJT. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast. Ann Surg Oncol. 2008;15(1):235-243.PubMedCrossRef
42.
Liu Y, Perez M, Aft RL, Massman K, Robinson E, Myles S, et al. Accuracy of perceived risk of recurrence among patients with early-stage breast cancer. Canc Epidemiol Biomarkers Prev. 2010;19(3):675-680.CrossRef
43.
Liu Y, Perez M, Schootman M, Aft RL, Gillanders WE, Ellis MJ, et al. A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer. Breast Cancer Res Treat. 2010;124(3):835-844. Epub 2010/05/07.PubMedCrossRef
44.
Karakoyun-Celik O, Gorken I, Sahin S, Orcin E, Alanyali H, Kinay M. Depression and anxiety levels in woman under follow-up for breast cancer: Relationship to coping with cancer and quality of life. Med Oncol. 2010;27(1):108-113. Epub 2009 Feb 19.PubMedCrossRef
45.
Magai C, Consedine NS, Adjei BA, Hershman D, Neugut A. Psychosocial influences on suboptimal adjuvant breast cancer treatment adherence among African American women: Implications for education and intervention. Health Educ Behav. 2008;35(6):835-854. Epub 2007 Oct 1.PubMedCrossRef
46.
Sehdev S, Martin G, Sideris L, Lam W, Brisson S. Safety of adjuvant endocrine therapies in hormone receptor-positive early breast cancer. Curr Oncol. 2009;16(Suppl 2):S14-S23.PubMed
47.
Kemppainen JK, Levine RE, Mistal M, Schmidgall D. HAART adherence in culturally diverse patients with HIV/AIDS: A study of male patients from a Veteran’s Administration Hospital in northern California. AIDS Patient Care STDS. 2001;15(3):117-127.PubMedCrossRef
48.
Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L, et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011;126(2):529-537. Epub 2010/08/31.PubMedCrossRef
49.
Weiss D, Marmar C. The impact of event scale—revised. In: Wilson J, Keane T, eds. Assessing psychological trauma and PTSD. New York: Guilford; 1997:399-411.
50.
Metadaten
Titel
Worry About Cancer Progression and Low Perceived Social Support: Implications for Quality of Life Among Early-Stage Breast Cancer Patients
verfasst von
Erika A. Waters, PhD, MPH
Ying Liu, MD, PhD
Mario Schootman, PhD
Donna B. Jeffe, PhD
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Annals of Behavioral Medicine / Ausgabe 1/2013
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-012-9406-1

Weitere Artikel der Ausgabe 1/2013

Annals of Behavioral Medicine 1/2013 Zur Ausgabe

INTRODUCTION

Introduction to the Second Special Section on Health Disparities

Original Article

State and Trait Pain Catastrophizing and Emotional Health in Rheumatoid Arthritis

Original Article

The Alberta Diabetes and Physical Activity Trial (ADAPT):A Randomized Trial Evaluating Theory-Based Interventions to Increase Physical Activity in Adults with Type 2 Diabetes

Original Article

Distinct Depression Symptom Trajectories over the First Year of Dialysis: Associations with Illness Perceptions

Original Article

Physical Activity and Differential Methylation of Breast Cancer Genes Assayed from Saliva: A Preliminary Investigation

Original Article

Affective Reactivity to Daily Stressors and Long-Term Risk of Reporting a Chronic Physical Health Condition

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Bildnachweise